$10MSeed, 13 January 2026
Raised over $10M led by YK Bioventures to advance targeted immunotherapies for cold solid tumors.
- Amount
- $10M
- Stage
- Seed
- Announced
- 13 January 2026
- Lead
- YK Bioventures
- Other investors
- Pillar, Berkeley Frontier Fund, Freeflow Ventures, National Cancer Institute
- Use of funds
- Raised over $10M led by YK Bioventures to advance targeted immunotherapies for cold solid tumors.
- Checked
- Amount and date checked against the press source
- Source
- Vivere Oncotherapies Raises Over $10 Million To Advance Targeted Immunotherapies For ‘Cold’ Solid Tumors pulse2.com